US Stock MarketDetailed Quotes

HUMA Humacyte

Watchlist
  • 3.900
  • +0.080+2.09%
Close Apr 25 16:00 ET
  • 3.920
  • +0.020+0.51%
Pre 08:46 ET
464.43MMarket Cap-3644P/E (TTM)

About Humacyte Company

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Company Profile

SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
Founded2004
CEOMs. Laura E. Niklason
MarketNASDAQ
Employees185
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633

Company Executives

  • Name
  • Position
  • Salary
  • Laura E. Niklason
  • President, Chief Executive Officer and Director
  • 1.75M
  • Shamik J. Parikh
  • Chief Medical Officer
  • 1.53M
  • Dale A. Sander
  • Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
  • 982.97K
  • William John Scheessele
  • Chief Commercial Officer
  • --
  • Dr. Cindy Cao
  • Chief Regulatory Officer
  • --
  • Dr. Heather Prichard
  • Chief Operating Officer
  • --
  • Kathleen Sebelius
  • Chairman of the Board
  • 103.00K
  • Brady W. Dougan
  • Director
  • 78.00K
  • Rajiv Shukla
  • Director
  • 78.00K
  • Todd M. Pope
  • Independent Director
  • 83.00K
  • Dr. Emery N. Brown
  • Independent Director
  • 78.00K
  • C. Bruce Green
  • Independent Director
  • 55.23K
  • Diane Seimetz
  • Independent Director
  • 70.84K
  • Michael T. Constantino
  • Independent Director
  • 85.50K
  • Max Wallace
  • Independent Director
  • 83.00K
  • Gordon M. Binder
  • Independent Director
  • 78.00K
  • Dr. Susan Richards Windham-Bannister, PhD
  • Independent Director
  • 78.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg